Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease

Authors: Veronika Bachanová, D I Marks, M-J Zhang, Hai‐Lin Wang, Marcos de Lima, Mahmoud Aljurf, Martha Arellano, Andrew Artz, Ulrike Bacher, J-Y Cahn, Y-B Chen, Edward A. Copelan, William R. Drobyski, Robert Peter Gale, John P. Greer, Vikas Gupta, Gregory A. Hale, Partow Kebriaei, Hillard M. Lazarus, Ian D. Lewis, Victor Lewis, Jane L. Liesveld, Mark R. Litzow, Alison W. Loren, Alan M. Miller, Maxim Norkin, Betül Oran, Joseph Pidala, Jacob M. Rowe, Bipin N. Savani, Wael Saber, Ravi Vij, Edmund K. Waller, Peter H. Wiernik, Daniel J. Weisdorf - Leukemia 2013 cited by 135